Full-Time

Director – Pharmacovigilance Quality Assurance

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$218.4k - $256.9kAnnually

Senior

San Carlos, CA, USA

Requires on-site attendance three days a week.

Category
QA & Testing
Quality Assurance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Experience in audit and inspection management, with a track record of successful regulatory audits
  • Exceptional communication skills, with the ability to interact with senior leadership and external stakeholders
  • Ability to perform GVP audits is required
  • Experience in developing GVP SOPs and training personnel regarding those SOPs and the government regulations to which they respond
  • Thorough understanding of the quality systems that support internal GVP activities for documentation of development and commercial products
  • Advanced Microsoft application skills (Word, Excel, PowerPoint)
  • Experience in developing GVP processes for the best industry practices and training personnel
  • BA/BS degree in biological sciences, pharmacy, related field, or equivalent experience
  • 10+ years of experience in pharmacovigilance, including at least 5 years in a leadership or management role including experience in development and maintenance of pharmacovigilance quality systems and performing pharmacovigilance audits for clinical and commercial stage pharmaceutical companies
  • Hands-on experience with safety database systems, including validation, audits, and compliance assessments
  • In-depth knowledge of global pharmacovigilance regulations, guidelines (e.g., ICH, GVP, other GxP), and safety reporting requirements is required
Responsibilities
  • Lead Clinical Quality Assurance activities and work with DSPV team to support success of the DSPV processes, systems, training and compliance programs for both development and marketed products
  • Champion and influence management and growth of the Clinical Quality Assurance team with the goal of attracting and developing talent, creating a rewarding professional environment, and ensuring that the team’s capabilities meet Corcept’s future needs
  • Serve as a QA representative and support DSPV team’s procedures and processes to provide compliance advice and strategy that is in accordance with world-wide regulatory requirements
  • Provide strategic and compliance advice; participate in the review and approval of required DSPV documents
  • Oversee the pharmacovigilance quality management system (QMS), ensuring compliance with global regulatory requirements (e.g., FDA, EMA, ICH, GxP)
  • Work with Drug Safety and Pharmacovigilance, IT and other departments to ensure that the safety database is appropriately validated and maintained in compliance with regulatory requirements (e.g., 21 CFR Part 11)
  • Perform ongoing gap assessment of the DSPV QMS and feed into the audit plan
  • Develop, manage and implement DSPV Audit Plan using risk-based approach for DSPV activities. Conduct audits as necessary of DSPV process, documentation and service providers
  • Set inspection readiness strategy for DSPV. Manage and support inspection readiness activities for DSPV
  • Manage DSPV related inspections conducted by regulatory agencies, including sponsor inspections, post-marketing Adverse Drug Experience (PADE) inspections, and contract research organization (CRO) inspections
  • Oversee the preparation and response to regulatory audits and inspections, ensuring readiness and adherence to regulatory requirements
  • Oversee the development of training programs for pharmacovigilance staff to ensure awareness and adherence to quality standards
  • Conduct and/or manage qualification of DSPV service providers
  • Lead and/or support DSPV non-compliance event investigations and CAPA implementation that may include monitoring non-compliance trends and effectiveness checks
  • Lead metric analyses for DSPV including development and management of KPIs and KQIs for determining the effectiveness of the overall DSPV QMS
  • Maintain knowledge of agency and industry trends, standards, and methodologies related to GVPs and notify changes to the applicable teams including possible training
  • Provide cross training development opportunities; mentor and coach junior QA team members
  • Travel required
  • This headquarters-based role requires on-site attendance three days a week

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing stress, metabolism, and immune functions. Their main product, Korlym, is an FDA-approved medication for Cushing's syndrome, a condition caused by excessive cortisol. Corcept has created over 1,000 unique cortisol modulators through extensive research and development. Unlike many competitors, Corcept emphasizes both drug development and patient education, providing resources to healthcare professionals and patients to enhance understanding of cortisol-related disorders. The company's goal is to expand its range of treatments for conditions linked to cortisol imbalance while improving patient care.

Company Stage

IPO

Total Funding

$42.6M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

23%

1 year growth

31%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from firms like Intrinsic Edge Capital and Jackson Creek Investment Advisors indicate strong market confidence in Corcept's growth potential.
  • The appointment of experienced leaders like Roberto Vieira and Monica Tellado suggests a strategic focus on expanding into oncology and emerging markets.
  • Corcept's commitment to patient and medical education enhances its reputation and fosters better patient outcomes.

What critics are saying

  • Ongoing legal disputes, such as the antitrust lawsuit from Teva, could result in financial and operational setbacks.
  • The loss of the Korlym patent lawsuit to Teva poses a significant threat to Corcept's revenue stream from its flagship product.

What makes Corcept Therapeutics unique

  • Corcept Therapeutics specializes exclusively in cortisol modulation, setting it apart from broader-focused biopharmaceutical companies.
  • Their flagship product, Korlym, is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome, giving them a unique market position.
  • Corcept's extensive R&D pipeline with over 1,000 discovered selective cortisol modulators highlights their commitment to innovation in this niche field.

Help us improve and share your feedback! Did you find this helpful?